Literature DB >> 17723312

Affective pain modulation in fibromyalgia, somatoform pain disorder, back pain, and healthy controls.

Bettina S Arnold1, Georg W Alpers, Holger Süss, Eckart Friedel, Gregor Kosmützky, Antje Geier, Paul Pauli.   

Abstract

Previous research suggested that patients with fibromyalgia (FM) experience a higher pain intensity (clinical pain) than do patients with musculoskeletal pain after negative emotional priming compared to positive priming. To further examine affective pain modulation in FM, we applied an experimental pain induction to compare 30 patients with FM with 30 healthy (pain-free) participants (HC), and 30 patients with back pain (BP). For another group of 30 patients with somatoform pain disorder (SF), we predicted the same pain modulation as for FM. As primes we presented positive, neutral, negative, and pain-related pictures and assessed pain intensity in response to a fixed pressure weight. Overall, picture valence modulated pain intensities (in the order of pain-related > negative pictures > neutral), but the pain intensities between neutral and positive pictures did not differ significantly. SF reported significantly higher pain intensities than did BP and HC; FM were in between, but did not differ significantly from the three other groups. There was no interaction of priming and group. Affective modulation of pain was not specifically altered in FM and SF, but SF were more sensitive to pressure pain than BP and HC.

Entities:  

Mesh:

Year:  2007        PMID: 17723312     DOI: 10.1016/j.ejpain.2007.06.007

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  11 in total

Review 1.  Central pain mechanisms in chronic pain states--maybe it is all in their head.

Authors:  Kristine Phillips; Daniel J Clauw
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-04       Impact factor: 4.098

Review 2.  The role of positive affect in pain and its treatment.

Authors:  Patrick H Finan; Eric L Garland
Journal:  Clin J Pain       Date:  2015-02       Impact factor: 3.442

3.  Prospective replication study implicates the catechol-O-methyltransferase Val158Met polymorphism as a biomarker for the response to morphine in patients with cancer.

Authors:  Hiromichi Matsuoka; Chihiro Makimura; Atsuko Koyama; Yoshihiko Fujita; Junji Tsurutani; Kiyohiro Sakai; Ryo Sakamoto; Kazuto Nishio; Kazuhiko Nakagawa
Journal:  Biomed Rep       Date:  2017-08-08

4.  Pain-related and negative semantic priming enhances perceived pain intensity.

Authors:  Maria Richter; Christoph Schroeter; Theresa Puensch; Thomas Straube; Holger Hecht; Alexander Ritter; Wolfgang H R Miltner; Thomas Weiss
Journal:  Pain Res Manag       Date:  2014 Mar-Apr       Impact factor: 3.037

Review 5.  Cognitive and emotional control of pain and its disruption in chronic pain.

Authors:  M Catherine Bushnell; Marta Ceko; Lucie A Low
Journal:  Nat Rev Neurosci       Date:  2013-05-30       Impact factor: 34.870

6.  [Somatoform disorders with pain as the predominant symptom: results to distinguish a common group of diseases].

Authors:  R Nickel; J Hardt; B Kappis; R Schwab; U T Egle
Journal:  Schmerz       Date:  2009-08       Impact factor: 1.107

Review 7.  TMD and chronic pain: a current view.

Authors:  Bruno D'Aurea Furquim; Lívia Maria Sales Pinto Flamengui; Paulo César Rodrigues Conti
Journal:  Dental Press J Orthod       Date:  2015 Jan-Feb

8.  How words impact on pain.

Authors:  Alexander Ritter; Marcel Franz; Wolfgang H R Miltner; Thomas Weiss
Journal:  Brain Behav       Date:  2019-08-01       Impact factor: 2.708

9.  Influence of acute pain on valence rating of words.

Authors:  Christoph Brodhun; Eleonora Borelli; Thomas Weiss
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

10.  Positive affect and chronic pain: a preregistered systematic review and meta-analysis.

Authors:  Anthony D Ong; Felix Thoemmes; Kaylin Ratner; Kate Ghezzi-Kopel; M Carrington Reid
Journal:  Pain       Date:  2020-06       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.